Make us your home page
Instagram

Under fire for high prices, Valeant to sell some drugs for less at Walgreens

CHICAGO — Stung by criticism that it jacked up the price of lifesaving medicines, Valeant Pharmaceuticals said Tuesday it will lower some prices through an agreement with Chicago-based Walgreens, the nation's largest pharmacy retailer.

Valeant said its "fulfillment agreement" will cut prices 10 percent on all skin and eye medicines, and more than 50 percent on some other branded drugs that have generics available. The lower prices will be phased in over the next six to nine months, said Valeant, based in Laval, Quebec.

In recent months, Valeant caused a furor by sharply increasing prices for heart drugs shortly after buying them from Marathon Pharmaceuticals, a small drug developer from suburban Chicago. Valeant raised the price of Nitropress more than 200 percent and the price of Isuprel more than 500 percent.

Those kinds of sharp increases by Valeant and other drugmakers have come under intense national scrutiny. Last week, the Senate Special Committee on Aging held a hearing on drug prices. The House Oversight Committee is expected to hold hearings early next year. That attention is pressuring the pharmaceutical industry to defend its prices or to denounce drugmakers that have pushed through extraordinarily high price increases.

Valeant said its 20-year agreement would allow customers to buy certain products at lower out-of-pocket costs from more than 8,000 Walgreens stores, as well as an unspecified number of participating independent retailers. The arrangement will take affect early next year and will initially cover Valeant's dermatology products, including Jublia, Luzu and Solodyn, and eye products including Besivance and Lotemax.

Under fire for high prices, Valeant to sell some drugs for less at Walgreens 12/15/15 [Last modified: Tuesday, December 15, 2015 6:51pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times

    

Join the discussion: Click to view comments, add yours

Loading...
  1. Tampa Bay Times honored for top investigative story in Gerald Loeb annual business awards

    Business

    The Tampa Bay Times was a co-winner in the investigative category for one of the highest honors in business journalism.

    Tampa Bay Times current and former staff writers William R. Levesque, Nathaniel Lash and Anthony Cormier were honored in the investigative category for their coverage of "Allegiant Air" in the 60th Anniversary Gerald Loeb Awards for Distinguished Business and Financial Journalism. 
[JAMES BORCHUCK   |   Times

]

  2. Strategic Property Partners launches website for Water Street Tampa

    Business

    Strategic Property Partners has launched its official website for Water Street Tampa, its 53-acre redevelopment project in downtown Tampa Tuesday.

    Strategic Property Partners on Tuesday announced the name of its new development: Water Street Tampa. [Photos courtesy of SPP]
  3. ReliaQuest CEO Brian Murphy named sole Tampa Bay winner in EY state entrepreneur contest

    Business

    ReliaQuest founder and CEO Brian Murphy was named one of nine winners statewide and the only one from the Tampa Bay area in the Ernst and Young Entrepreneur Of The Year 2017 Florida Awards program. Murphy won in the IT security division after starting ReliaQuest in 2007. Five of the nine winners were from the Miami …

    Tampa's ReliaQuest founder and CEO Brian Murphy was named one of nine winners statewide and the only one from the Tampa Bay area in the Ernst and Young Entrepreneur Of The Year 2017 Florida Awards program. Murphy won in the IT security division after starting ReliaQuest in 2007.
  4. U.S. Rep. Charlie Crist and estranged wife Carole put Beach Drive condo on the market

    Real Estate

    ST. PETERSBURG — U.S. Rep. Charlie Crist and his estranged wife, Carole, have put their Beach Drive condo on the market for $1.5 million.

    Former Florida Gov. and current U.S. Rep. Charlie Crist and his estranged wife, Carole, have put their condo in downtown St. Petersburg on the market for $1.5 million. [Courtesy of Rhonda Sanderford]